1. Home
  2. SNAL vs CTSO Comparison

SNAL vs CTSO Comparison

Compare SNAL & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Snail Inc.

SNAL

Snail Inc.

SELL

Current Price

$2.34

Market Cap

21.2M

Sector

Technology

ML Signal

SELL

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

SELL

Current Price

$4.52

Market Cap

23.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SNAL
CTSO
Founded
2000
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
23.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
SNAL
CTSO
Price
$2.34
$4.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $32.50
AVG Volume (30 Days)
★ 150.0K
22.2K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 120.00
65.79
EPS
★ N/A
N/A
Revenue
★ $81,225,622.00
$22,503,908.00
Revenue This Year
$25.62
$2.14
Revenue Next Year
$7.81
$16.24
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$0.59
$0.30
52 Week High
$21.60
$7.44

Technical Indicators

Market Signals
Indicator
SNAL
CTSO
Relative Strength Index (RSI) 52.03 46.03
Support Level $1.92 $2.88
Resistance Level $2.63 $7.20
Average True Range (ATR) 0.31 0.79
MACD 0.03 -0.07
Stochastic Oscillator 46.55 15.43

Price Performance

Historical Comparison
SNAL
CTSO

About SNAL Snail Inc.

Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: